Vancouver, British Columbia--(Newsfile Corp. - March 19, 2015) - True Leaf Medicine International Ltd. (CSE: MJ) (FSE: TLA) (the "company" or "True Leaf") announced today that the company's board of directors has granted a total of 3,750,000 incentive stock options at a price of $0.10 per share exercisable for a two-year period from the date of grant.

Of the 3,750,000 options, 2,500,000 have been issued to directors and officers of the company, with the remaining issued to True Leaf team members. Prior to this issue, the company did not have outstanding incentive options.

About True Leaf International Ltd.

True Leaf Medicine International Ltd. has filed an application under Health Canada's Marihuana for Medicinal Purposes Regulations (MMPR) to become a licensed producer with a facility located in the Village of Lumby, BC. The company has passed through the preliminary and enhanced screening process of Health Canada's review and is currently awaiting a 'ready-to-build' approval.

For more information, please see True Leaf's website at www.trueleaf.com.

Investor Inquiries

Kevin Bottomley | Director
778.389.9933
kevin@trueleaf.com

On Behalf of the Board of Directors

True Leaf Medicine International Ltd.

Michael Harcourt
Chairman

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

 FORWARD LOOKING INFORMATION

This press release contains forward-looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks various risk factors discussed in the Company's Management's Discussion and Analysis under the Company's profile on www.sedar.com. While the Company may elect to, it does not undertake to update this information at any particular time.